{"id":825244,"date":"2026-07-26T16:36:14","date_gmt":"2026-07-26T16:36:14","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/825244\/"},"modified":"2026-07-26T16:36:14","modified_gmt":"2026-07-26T16:36:14","slug":"asthma-experts-explain-key-asthma-topics-in-quick-updates","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/825244\/","title":{"rendered":"Asthma experts explain key asthma topics in quick updates"},"content":{"rendered":"<p>More than\u00a0<a href=\"https:\/\/www.aihw.gov.au\/reports\/chronic-respiratory-conditions\/asthma\" rel=\"nofollow noopener\" target=\"_blank\">1 in 10 Australians have asthma<\/a>, and it is the\u00a0<a href=\"https:\/\/www.aihw.gov.au\/reports\/chronic-respiratory-conditions\/asthma\" rel=\"nofollow noopener\" target=\"_blank\">leading cause of disease burden in children aged 1\u20139 years<\/a>.<\/p>\n<p>Each year asthma results in more than\u00a0<a href=\"https:\/\/www.aihw.gov.au\/reports\/chronic-respiratory-conditions\/asthma\" rel=\"nofollow noopener\" target=\"_blank\">60\u00a0000 emergency department presentations<\/a>. Australian research shows\u00a0<a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.5694\/mja14.01564\" rel=\"nofollow noopener\" target=\"_blank\">almost half<\/a> of adults and older adolescents with asthma have poor asthma control, and that\u00a0<a href=\"https:\/\/www.woolcock.org.au\/news\/beyond-the-blue-puffer\" rel=\"nofollow noopener\" target=\"_blank\">most people with asthma could have fuller and more active lives<\/a> with better asthma management.<\/p>\n<p>Asthma management can be complex, so the\u00a0<a href=\"https:\/\/www.nationalasthma.org.au\" rel=\"nofollow noopener\" target=\"_blank\">National Asthma Council Australia<\/a> has published a series of short topic updates prepared with panels of asthma experts, to help primary care clinicians follow national guidelines in the\u00a0<a href=\"https:\/\/www.asthmahandbook.org.au\/\" target=\"_blank\" rel=\"nofollow noopener\">Australian Asthma Handbook<\/a>, updated late 2025:<\/p>\n<p>Each\u00a0information sheet includes a Q&amp;A, dosage guides, and key messages for patients.<\/p>\n<p>Australia has a problem with over-reliance on \u2018blue puffers\u2019<\/p>\n<p>Many Australians with asthma are at risk of severe asthma exacerbations due to\u00a0<a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/overcoming-australias-over-reliance-on-blue-puffers-for-asthma\" rel=\"nofollow noopener\" target=\"_blank\">over-reliance on short-acting beta2 agonists<\/a> (SABAs) like salbutamol and terbutaline: they either manage their asthma entirely with over-the-counter salbutamol, or have been prescribed an inhaled corticosteroid (ICS) but don\u2019t use it as intended.\u00a0<a href=\"https:\/\/bmjopen.bmj.com\/content\/bmjopen\/9\/8\/e028995.full.pdf\" rel=\"nofollow noopener\" target=\"_blank\">Australian research<\/a> also suggests 70% of adults and late adolescents with asthma use salbutamol more than twice a week on average \u2014 enough to be at risk of hospital presentations.<\/p>\n<p><a href=\"https:\/\/www.asthmahandbook.org.au\" rel=\"nofollow noopener\" target=\"_blank\">Australian guidelines<\/a> recommend that no-one aged 12 years or more should manage their asthma solely with a SABA. It is also inadequate asthma treatment for most school-aged children and many preschool children. The message to patients and parents is that a \u2018blue puffer\u2019 doesn\u2019t treat the cause of asthma, or prevent symptoms or attacks.\u00a0<\/p>\n<p>What\u2019s the alternative to reliance on salbutamol? For\u00a0<a href=\"https:\/\/www.asthmahandbook.org.au\/management\/children-6-11-years\/medication-management\/initial-asthma-treatment-for-children-6-11-years-after-diagnosis\" rel=\"nofollow noopener\" target=\"_blank\">school-aged<\/a> and\u00a0<a href=\"https:\/\/www.asthmahandbook.org.au\/management\/children-1-5-years\/medication-management\/initial-asthma-treatment-for-children-1-5-years-after-diagnosis\" rel=\"nofollow noopener\" target=\"_blank\">preschool<\/a> children, the key message is not to delay prescribing a low daily maintenance dose of ICS, if indicated. For adults and adolescents, asthma treatment based on\u00a0<a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/anti-inflammatory-reliever-is-the-recommended-starting-treatment-for-asthma\" rel=\"nofollow noopener\" target=\"_blank\">anti-inflammatory relievers<\/a> is now recommended.\u00a0<\/p>\n<p>Switch to anti-inflammatory reliever<\/p>\n<p>The minimal level of asthma treatment is now budesonide-formoterol taken as needed for symptoms. This \u2018<a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/anti-inflammatory-reliever-is-the-recommended-starting-treatment-for-asthma\" rel=\"nofollow noopener\" target=\"_blank\">anti-inflammatory reliever-only<\/a>\u2019 therapy is suitable for patients who don\u2019t need daily maintenance treatment, including most adults and adolescents with newly diagnosed asthma.<\/p>\n<p>Symptom-driven dosing lets patients adjust their own treatment level, and overcomes the common problem of\u00a0<a href=\"https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/02770903.2020.1711916\" rel=\"nofollow noopener\" target=\"_blank\">poor adherence to daily maintenance ICS treatment<\/a>. Australian-led\u00a0<a href=\"https:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600(20)30416-1\/abstract\" rel=\"nofollow noopener\" target=\"_blank\">research<\/a> shows that dose-escalation with anti-inflammatory reliever in response to worsening asthma symptoms is much more effective than SABA for preventing progression to severe asthma exacerbations. If the reliever is needed on three or more days per week, a maintenance dose can be added.<\/p>\n<p>Only certain budesonide-formoterol inhalers can be used this way \u2014 see the\u00a0<a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/anti-inflammatory-reliever-is-the-recommended-starting-treatment-for-asthma\" rel=\"nofollow noopener\" target=\"_blank\">comprehensive list with a dosage guide<\/a>. Anti-inflammatory reliever use in children under 12 years is currently not approved by the Therapeutic Goods Administration.<\/p>\n<p>The message for patients used to be \u2018you must take your asthma preventer every day, forever\u2019. That\u2019s still best for some, but many people can now use a combination inhaler just when they need it, and still get the benefit. Every dose helps relieve inflammation in the airways as well as quickly relieving the symptoms.<\/p>\n<p>Add anti-inflammatory maintenance treatment when indicated<\/p>\n<p><a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/anti-inflammatory-reliever-is-the-recommended-starting-treatment-for-asthma\" rel=\"nofollow noopener\" target=\"_blank\">Maintenance-and-reliever therapy<\/a> (MART) with budesonide-formoterol (patients \u226512 years) or beclometasone-formoterol (patients \u2265 18 years) is now recommended instead of maintenance inhaled corticosteroids plus as-needed SABA. The patient uses their inhaler for daily or twice-daily preventive treatment, and takes extra doses as needed for symptom relief.<\/p>\n<p>This approach\u00a0<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5876810\" rel=\"nofollow noopener\" target=\"_blank\">reduces severe exacerbations<\/a> compared with a maintenance dose of ICS in combination with a long-acting beta2 agonist (LABA) plus a separate SABA reliever: by approximately 32% compared with the same ICS dose, and by 23% compared with a higher ICS dose.\u00a0<\/p>\n<p>Only certain combination inhalers can be used as MART \u2014 see the\u00a0<a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/maintenance-and-reliever-therapy-for-asthma\" rel=\"nofollow noopener\" target=\"_blank\">comprehensive list and dosage guide<\/a>.<\/p>\n<p>For difficult asthma, investigate and refer<\/p>\n<p>When good asthma control isn\u2019t achieved despite treatment with medium-dose ICS-LABA in a\u00a0<a href=\"https:\/\/www.asthmahandbook.org.au\/management\/adults-and-adolescents\/medication-management\/treatment-levels-for-adults-and-adolescents\" rel=\"nofollow noopener\" target=\"_blank\">recommended regimen<\/a>, take a stepwise approach. First\u00a0<a href=\"https:\/\/www.asthmahandbook.org.au\/management\/adults-and-adolescents\/medication-management\/managing-difficult-to-treat-asthma-in-adults-and-adolescents\" rel=\"nofollow noopener\" target=\"_blank\">check for common causes<\/a>: low adherence, incorrect inhaler technique, exposure to cigarette smoke, allergens, or indoor\/outdoor air pollution, and any problems interfering with self-management. Consider comorbidities.<\/p>\n<p>If the problem persists,\u00a0<a href=\"https:\/\/www.asthmahandbook.org.au\/management\/adults-and-adolescents\/medication-management\/managing-difficult-to-treat-asthma-in-adults-and-adolescents\" rel=\"nofollow noopener\" target=\"_blank\">current guidelines<\/a> recommend blood eosinophil count and spirometry \u2014 preferably at an accredited respiratory laboratory that can provide an exhaled nitric oxide (FeNO) test \u2014 along with routine referral to a respiratory specialist.<\/p>\n<p>If specialist assessment is not immediately available, consider a short treatment trial with either a high dose of ICS-LABA, or \u2018<a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/triple-therapy-for-asthma-in-primary-care\" rel=\"nofollow noopener\" target=\"_blank\">triple therapy<\/a>\u2019 that includes a long-acting muscarinic antagonist (LAMA). Triple therapy options include tiotropium in a separate inhaler added to any ICS-LABA combination, and single-inhaler triple combinations \u2014 see the\u00a0<a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/triple-therapy-for-asthma-in-primary-care\" rel=\"nofollow noopener\" target=\"_blank\">full list with age restrictions and a dosage guide<\/a>.<\/p>\n<p>Any patient with a raised eosinophil count or raised FeNO, indicating type 2 airway inflammation, needs specialist assessment for monoclonal antibody therapy to reduce the risk of severe exacerbations.<\/p>\n<p>The key message is that prolonged triple therapy should not replace prompt specialist assessment, because many patients with severe asthma will benefit most from\u00a0<a href=\"https:\/\/insightplus.mja.com.au\/2025\/23\/fast-tracking-monoclonal-antibody-therapy-for-patients-with-severe-asthma\" rel=\"nofollow noopener\" target=\"_blank\">fast-tracking for monoclonal antibody therapy<\/a>.<\/p>\n<p>Minimise the use of systemic corticosteroids<\/p>\n<p>Short courses of oral prednisone\/prednisolone used to be considered fairly harmless, but a\u00a0<a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.2147\/JAA.S176026#d1e190\" rel=\"nofollow noopener\" target=\"_blank\">longitudinal observational study<\/a> and\u00a0<a href=\"https:\/\/publications.ersnet.org\/content\/erj\/60\/3\/2103054.full.pdf\" rel=\"nofollow noopener\" target=\"_blank\">large database study<\/a> have found serious long-term effects in adults after even a few short courses to manage asthma exacerbations. In children, the use of multiple short courses for asthma\u00a0<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2928657\/pdf\/nihms227833.pdf\" rel=\"nofollow noopener\" target=\"_blank\">reduces bone mineral density<\/a>. \u2018Toxic\u2019 doses are\u00a0<a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.5694\/mja2.50758\" rel=\"nofollow noopener\" target=\"_blank\">frequently dispensed<\/a> in Australia.<\/p>\n<p>This has led to calls for corticosteroid stewardship from\u00a0<a href=\"https:\/\/thoracic.org.au\/oral-corticosteroids-stewardship-for-asthma-in-adults-and-adolescents-a-position-paper-from-the-thoracic-society-of-australia-and-new-zealand\" rel=\"nofollow noopener\" target=\"_blank\">Thoracic Society of Australia and New Zealand<\/a>.\u00a0<a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/oral-corticosteroid-use-in-asthma-whats-safe-and-appropriate\" rel=\"nofollow noopener\" target=\"_blank\">Strategies\u00a0<\/a>include using ICS to prevent exacerbations, writing PBS scripts for the required quantity with no repeats, and cautioning patients and parents against casual use of leftover tablets or liquids when asthma symptoms occur.<\/p>\n<p>Update your asthma knowledge<\/p>\n<p>National Asthma Council\u2019s information sheets provide a concise update on all these key asthma topics. Find them and other asthma resources on the\u00a0<a href=\"https:\/\/www.nationalasthma.org.au\/living-with-asthma\/resources\/health-professionals\/information-paper\/oral-corticosteroid-use-in-asthma-whats-safe-and-appropriate\" rel=\"nofollow noopener\" target=\"_blank\">website<\/a>.<\/p>\n<p>Clinical Associate Professor Debbie Rigby, Clinical Executive Lead, National Asthma Council Australia, is an advanced practice pharmacist with over 40 years\u2019 experience across clinical pharmacy practice, interdisciplinary care, policy and advocacy, clinical governance, guidelines development and education. She has a specific interest in respiratory conditions and has been credentialed as an asthma educator. She is also passionate about improving the care and support for people living with asthma through multidisciplinary patient-centred care, shared decision making and evidence-based medicine.<\/p>\n<p>Dr Tim Jones is a Tasmanian GP, rural generalist, GP supervisor, medical educator and PHN board director. He is Chair of Specific Interests, Child and Young Person&#8217;s Health at the RACGP, Senior Medical Educator &amp; Deputy Faculty Chair of RACGP Tasmania, and a member of the National Asthma Council Australia Guidelines Committee.\u00a0<\/p>\n<p>The statements or opinions expressed in this article reflect the views of the authors and do not necessarily represent the official policy of the AMA, the\u00a0MJA\u00a0or\u00a0InSight+\u00a0unless so stated.\u00a0<\/p>\n<p>Subscribe to the free\u00a0InSight+\u00a0weekly newsletter\u00a0<a href=\"https:\/\/insightplus.mja.com.au\/insight-signup\" target=\"_blank\" rel=\"nofollow noopener\">here<\/a>. It is available to all readers, not just registered medical practitioners.\u00a0<\/p>\n<p>If you would like to submit an article for consideration, send a Word version to\u00a0<a href=\"https:\/\/insightplus.mja.com.au\/2026\/29\/mailto:mjainsight-editor@ampco.com.au\" target=\"_blank\" rel=\"nofollow noopener\">mjainsight-editor@ampco.com.au<\/a>.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"More than\u00a01 in 10 Australians have asthma, and it is the\u00a0leading cause of disease burden in children aged&hellip;\n","protected":false},"author":2,"featured_media":825245,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[64,63,137],"class_list":["post-825244","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-au","tag-australia","tag-health"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/825244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=825244"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/825244\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/825245"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=825244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=825244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=825244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}